losartan has been researched along with adenosine-3',5'-cyclic phosphorothioate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunette, MG; Charbonneau, A; Leclerc, M | 1 |
Davies, NW; Hayabuchi, Y; Standen, NB | 1 |
2 other study(ies) available for losartan and adenosine-3',5'-cyclic phosphorothioate
Article | Year |
---|---|
Effect of angiotensin II on calcium reabsorption by the luminal membranes of the nephron.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Kidney Tubules, Proximal; Losartan; Nephrons; Nitrendipine; Parathyroid Hormone; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Second Messenger Systems; Sodium; Thionucleotides; Vasoconstrictor Agents | 2001 |
Angiotensin II inhibits and alters kinetics of voltage-gated K(+) channels of rat arterial smooth muscle.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diglycerides; Enzyme Inhibitors; Isoenzymes; Kinetics; Losartan; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Peptides; Potassium Channels, Voltage-Gated; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Wistar; Thionucleotides; Vasoconstrictor Agents | 2001 |